Concepedia

Nabanita Nawar

NN

7

Publications

209

Citations

7

H-Index

2019

Active since

Affiliations

University of Toronto(Current)

Nabanita Nawar is an author at University of Toronto specializing in medicine, drug discovery, and molecular biology.

Top concepts

Publications per year

2019–2023

7

Publications

7

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia

Krimo Toutah, Nabanita Nawar, Sanna Timonen et al. · Journal of Medicinal Chemistry · 2021 · 43 citations · Full text

PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia

Justyna M. Gawel, Andrew E. Shouksmith, Yasir S. Raouf et al. · European Journal of Medicinal Chemistry · 2020 · 40 citations · Full text

, , +11

Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting

Muhammad Murtaza Hassan, Johan Israelian, Nabanita Nawar et al. · Journal of Medicinal Chemistry · 2020 · 38 citations · Full text

, , +15

Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma

Nabanita Nawar, Shazreh Bukhari, Ashley Adile et al. · Journal of Medicinal Chemistry · 2022 · 29 citations · Full text

Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype

Olasunkanmi O. Olaoye, P. R. Watson, Nabanita Nawar et al. · Journal of Medicinal Chemistry · 2021 · 26 citations · Full text

Rows per page

1–5 of 7